Venous thromboembolism

    Diagnosis, Diagnostic Test Accuracy (DTA) and Prognostic Reviews
    - Deep vein thrombosis (DVT)
    - Pulmonary embolism (PE)
    Intervention Reviews
    - Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patients
    - Prevention of VTE in acutely medically ill/high risk patients
    - Prevention of VTE in other patient groups
    - Prevention of post thrombotic syndrome (PTS)
    - Treatment of VTE
    - Treatment of DVT
    - Treatment of PE
    - Treatment of PTS
    - Other

    Diagnosis, Diagnostic Test Accuracy (DTA) and Prognosis reviews

    Deep Vein Thrombosis (DVT)

    Clinical decision rules for the diagnosis of deep vein thrombosis (title)

    Diagnostic tests for pregnancy-related deep vein thrombosis (title)

    Duplex ultrasound for the diagnosis of symptomatic deep vein thrombosis in the lower limb (protocol)

    Ultrasonography for clinically suspected upper extremity deep vein thrombosis (protocol)

    Pulmonary Embolism (PE)

    D-dimer test for excluding the diagnosis of pulmonary embolism

    Imaging for the exclusion of pulmonary embolism in pregnancy

    Sex as a prognostic factor in patients with symptomatic acute pulmonary embolism (title)


    Intervention reviews


    Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patient groups


    Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

    Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty

    Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement

    Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization 

    Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair (protocol)

    Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement

    Heparin dose for thrombosis prophylaxis during peripheral vascular angioplasty (protocol)

    Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures

    Interventions for prevention of venous thromboembolism for hip fractures or hip fracture surgery (title)

    Interventions for preventing venous thromboembolism following abdominal aortic surgery

    Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy

    Low molecular weight heparin for prevention of microvascular occlusion in digital replantation

    Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients (protocol)

    Pharmacological interventions for preventing venous thromboembolism in patients undergoing bariatric surgery (title)

    Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery

    Primary prophylaxis for venous thromboembolism in patients undergoing implantation of pacemakers or cardioverter-defibrillators (title)

    Primary prophylaxis for venous thromboembolism in patients undergoing major amputation of the lower extremity

     

    Prevention of VTE in acutely medically ill/high risk patient groups

    Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)

    Novel oral anticoagulants for prevention of venous thromboembolism in acutely ill medical patients (title)

    Standard versus extended duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients (title)


    Prevention of VTE in other patient groups

    Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid Syndrome (protocol)

    Antiplatelet and anticoagulant agents for primary prevention of thrombosis in patients with antiphospholipid antibodies

    Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism

    Compression stockings for preventing deep vein thrombosis in airline passengers

    Graduated compression stockings for prevention of deep vein thrombosis

    Heparin-bonded catheters for prolonging the patency of central venous catheters in children

    Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults

    Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children

    Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis

    Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children

    Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization

    Neuromuscular electrical stimulation for the prevention of venous thromboembolism

    Pentasaccharides for the prevention of venous thromboembolism

    Prevention of recurrent venous thromboembolism: an overview of Cochrane reviews (title)

    Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

    Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism

    Statins for primary prevention of venous thromboembolism

    Vena caval filters for the prevention of pulmonary embolism

    Prevention of Post Thrombotic Syndrome (PTS)

    Compression therapy for prevention of post-thrombotic syndrome

    Rutosides for prevention of post thrombotic syndrome


    Treatment of VTE

    Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism

    Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism 

    Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism

    Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism

    Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism

    Treatment for superficial thrombophlebitis of the leg

    Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism

    Warfarin initiation nomograms for venous thromboembolism

    Treatment of DVT

    Angioplasty for deep venous thrombosis (protocol)

    Antiplatelet agents for the treatment of deep venous thrombosis (protocol)

    Home versus in-patient treatment for deep vein thrombosis

    Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis

    Pentasaccharides for the treatment of deep vein thrombosis

    Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis

    Thrombolysis for acute deep vein thrombosis

    Thrombolysis for acute upper extremity deep vein thrombosis

    Treatment for distal deep vein thrombosis (title)

    Treatment of PE

    Anticoagulant treatment for subsegmental pulmonary embolism

    Catheter directed therapies for the treatment of massive and sub-massive acute pulmonary embolism (protocol)

    Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism

    Outpatient versus inpatient treatment for acute pulmonary embolism 

    Thrombolytic therapy for pulmonary embolism


    Treatment of PTS

    Rutosides for treatment of post-thrombotic syndrome

    Compression therapy for treating stage I and II (Widmer) post-thrombotic syndrome


    Other

    Effect of testing for cancer on cancer‐ and VTE‐related mortality and morbidity in patients with unprovoked VTE

    Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism

    Thrombophilia testing for prevention of recurrent venous thromboembolism (stable)

    Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients